CRISPR "gen teknologi"
-
Nogle så måske DR2 udsendelse om genterapi i dag, og evt. blev interesseret i at investere i et af de relativt få crispr-selskaber, der er børsnoterede. Igår steg det ene EDIT en del på følgende nyhed ang. en af de sygdomme der blev omtalt:
BRIEF-Editas Medicine Announces Second Quarter 2020 Results And Update
06-08-2020 Aug 6 (Reuters) - Editas Medicine Inc :EDITAS MEDICINE ANNOUNCES SECOND QUARTER 2020 RESULTS AND
UPDATE
Q2 LOSS PER SHARE $0.43
Q2 EARNINGS PER SHARE ESTIMATE $-0.79 -- REFINITIV IBES
DATA
PLAN TO FILE IND FOR EDIT-301 FOR SICKLE CELL DISEASE BY
END OF
2020Source text for Eikon:
Disclaimer.
Dette er IKKE en anbefaling, men blot info til personer, der måtte have fattet interesse efter at have set DR2 udsendelsen. Jeg kender selv til 3 andre børsnoterede crispr-selskaber NTLA (Intellia), CRSP (Crispr) og SGMO (Sangamo), som jeg selv har købt sammen med EDIT i 2017.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind